Qiu, T., Zhu, X., Wu, J., Hong, W., Hu, W., & Fang, T. (2025). Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-92282-4
Chicago-referens (17:e uppl.)Qiu, Ting, Xiaodong Zhu, Jingju Wu, Wenyuan Hong, Weitao Hu, och Taiyong Fang. "Mechanisms of Rifaximin Inhibition of Hepatic Fibrosis in Mice with Metabolic Dysfunction Associated Steatohepatitis Through the TLR4/NFκB Pathway." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-92282-4.
MLA-referens (9:e uppl.)Qiu, Ting, et al. "Mechanisms of Rifaximin Inhibition of Hepatic Fibrosis in Mice with Metabolic Dysfunction Associated Steatohepatitis Through the TLR4/NFκB Pathway." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-92282-4.
